Project Grant T35AI179601
Award Date
5/1/25
Completion Date
4/30/30
Dollars Obligated
$104K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Ohio, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $125,160 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Ohio State University to characterize a novel bacterial immune system. The research aims to use cryo-electron microscopy and biochemical assays to define the structure and assembly mechanisms of a bacterial immune complex consisting of two components, A and B, which are predicted to have ATPase and nuclease functions,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,462,682 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Ohio State University. The grant, effective June 5, 2024 through April 30, 2029, will support research to develop a mucosal subunit vaccine against SARS-CoV-2 that is effective against variants and generates long-lasting mucosal immunity. The research will test the hypothesis that a BCFA/alum-adjuvanted subunit vaccine containing...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,891,169 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Ohio State University to conduct research on the complex interactions between the bacterial pathogens Pseudomonas aeruginosa and Staphylococcus aureus. The research aims to define the mechanisms underlying their antagonistic and cooperative behaviors, with a focus on understanding how P. aeruginosa's exopolysaccharide Psl impacts...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $379,080 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Western University of Health Sciences to support a 2.5-month summer research education program. The program will strategically recruit and train 15 qualified, motivated, and research-oriented participants per year from the university's health professional student population, including those from underrepresented and disadvantaged...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $142,599 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas at San Antonio (UTSA). The goal of this 5-year grant is to recruit, train, and graduate a diverse group of doctoral students in multidisciplinary areas of molecular microbiology and immunology research at UTSA, a Hispanic-serving research institution. Key objectives include providing...
The University of Maryland, Baltimore was awarded a $367,474 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to implement the Supporting Under-Represented Minorities in Microbiology and Immunology Research (SUMMIR) program. The 5-year project (award date: Aug 16, 2024, ultimate completion date: Jul 31, 2029) aims to encourage and support individuals from underrepresented minority...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $229,163 Project Grant to The Ohio State University. The grant, with an award date of February 1, 2025 and an ultimate completion date of January 31, 2027, will support research to study the function of the HIV-1 envelope (Env) cytoplasmic tail domain and its role in viral trafficking and transmission. Specifically, the research aims to...
The University of Maryland, Baltimore (UMB) was awarded a $352,643 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, titled "Integrated Training Program in Vaccinology (ITP-VAX)", aims to encourage more trainees, particularly underrepresented minorities, to join the field of vaccinology and enable early-career vaccinologists to become independent researchers....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $351,180 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Oklahoma State University (OSU) to conduct research on the "Mechanisms and Dynamics of Superinfection Exclusion in Microviral Prophage Populations." The project aims to: a) understand the origin(s) of superinfection exclusion in microviral prophages, and b) investigate the influence of hypervariable region diversity on...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $705,557 to Emory University over the period from December 20, 2024 to November 30, 2029. The award aims to advance the understanding of protective mucosal innate and T cell immune responses against SARS-CoV-2 infection, with a focus on differentiating the contributions of these responses in the upper...